CN103408551B - 阿立塞替的制备方法 - Google Patents
阿立塞替的制备方法 Download PDFInfo
- Publication number
- CN103408551B CN103408551B CN201310316151.3A CN201310316151A CN103408551B CN 103408551 B CN103408551 B CN 103408551B CN 201310316151 A CN201310316151 A CN 201310316151A CN 103408551 B CN103408551 B CN 103408551B
- Authority
- CN
- China
- Prior art keywords
- lisai
- preparation
- phenyl
- chloro
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310316151.3A CN103408551B (zh) | 2013-07-25 | 2013-07-25 | 阿立塞替的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310316151.3A CN103408551B (zh) | 2013-07-25 | 2013-07-25 | 阿立塞替的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103408551A CN103408551A (zh) | 2013-11-27 |
CN103408551B true CN103408551B (zh) | 2015-08-05 |
Family
ID=49601607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310316151.3A Active CN103408551B (zh) | 2013-07-25 | 2013-07-25 | 阿立塞替的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103408551B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103788020B (zh) * | 2014-01-22 | 2015-11-04 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101014603A (zh) * | 2004-05-14 | 2007-08-08 | 千禧药品公司 | 通过抑制极光激酶抑制有丝分裂的化合物和方法 |
CN102770024A (zh) * | 2010-02-19 | 2012-11-07 | 米伦纽姆医药公司 | 4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式 |
WO2012167247A1 (en) * | 2011-06-03 | 2012-12-06 | Millennium Pharmaceuticals, Inc. | Combination of mek inhibitors and selective inhibitors of aurora a kinase |
-
2013
- 2013-07-25 CN CN201310316151.3A patent/CN103408551B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101014603A (zh) * | 2004-05-14 | 2007-08-08 | 千禧药品公司 | 通过抑制极光激酶抑制有丝分裂的化合物和方法 |
CN102770024A (zh) * | 2010-02-19 | 2012-11-07 | 米伦纽姆医药公司 | 4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式 |
WO2012167247A1 (en) * | 2011-06-03 | 2012-12-06 | Millennium Pharmaceuticals, Inc. | Combination of mek inhibitors and selective inhibitors of aurora a kinase |
Also Published As
Publication number | Publication date |
---|---|
CN103408551A (zh) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104496983B (zh) | 一种帕博西尼的制备方法 | |
CN104447743B (zh) | 帕博西尼的制备方法 | |
CN103626774B (zh) | 伊鲁替尼的制备方法 | |
CN102267985B (zh) | 维拉佐酮或其盐酸盐的制备方法 | |
CN103360396B (zh) | 一种替格瑞洛的制备方法 | |
CN107936029B (zh) | 一种合成瑞博西尼的方法 | |
CN103172636B (zh) | 吡啶并喹唑啉酮类化合物及其制备方法 | |
CN103288808B (zh) | 一种阿法替尼的制备方法 | |
CN103254180B (zh) | 一种阿伐那非的制备方法 | |
CN103288758B (zh) | 一种达克米替尼的制备方法 | |
CN103408551B (zh) | 阿立塞替的制备方法 | |
CN104478898A (zh) | 依维莫司及其中间体的制备方法 | |
CN110218189B (zh) | 一种阿贝西利中间体及阿贝西利的简便制备方法 | |
CN103980188A (zh) | 一种吡仑帕奈的合成方法及其中间体和中间体的合成方法 | |
CN104628719A (zh) | 一种制备苦马豆素[(-)-Swainsonine]的方法 | |
CN103880748B (zh) | 一种盐酸伊伐布雷定结构类似物及其制备方法和应用 | |
CN105061467A (zh) | 一种帕克替尼的制备方法 | |
CN108047182B (zh) | 一种西瑞香素衍生物及其应用 | |
US9688685B2 (en) | Method for preparing volasertib and intermediate thereof | |
CN103408520B (zh) | 3-[(2-氟-6-甲氧基)苯基]-5-氯苯酞及其制备方法 | |
CN103408552B (zh) | 阿立塞替的制备方法 | |
CN106432233A (zh) | N,N,6‑三甲基‑2‑(4‑甲基苯基)咪唑并[1,2‑a]吡啶‑3‑乙酰胺的制备方法 | |
CN103288759B (zh) | 达克米替尼的制备方法 | |
CN105418507A (zh) | 一种1-(3-甲基-1-苯基-1h-吡唑-5-基)哌嗪的制备方法 | |
CN103242244B (zh) | 一种卡奈替尼的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200513 Address after: 211200 Qinhuai Road, Lishui, Nanjing Yong Yang Street, No. Avenue, No. 288 Patentee after: Nanjing Zhiwu Intelligent Technology Co.,Ltd. Address before: 215000 Jiangsu Province, Suzhou City Industrial Park Commercial Plaza Building 1 room 1305 Lianfeng Co-patentee before: Xu Xuenong Patentee before: SUZHOU MIRACPHARMA TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201204 Address after: 215600 building 145, building A, emerging industry incubation center, Zhangjiagang Free Trade Zone, Suzhou, Jiangsu Patentee after: SUZHOU RUNTONG PATENT OPERATION Co.,Ltd. Address before: 211200 Qinhuai Road, Lishui, Nanjing Yong Yang Street, No. Avenue, No. 288 Patentee before: Nanjing Zhiwu Intelligent Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230915 Address after: No. 1 Minsheng Road, Daishi Town, Qianfeng District, Guang'an City, Sichuan Province, 638500 Patentee after: Wei Chunjiang Address before: 215600 room 145, A building, new industry incubation center, Zhangjiagang Free Trade Zone, Suzhou, Jiangsu Patentee before: SUZHOU RUNTONG PATENT OPERATION Co.,Ltd. |
|
TR01 | Transfer of patent right |